CGEN

Compugen Ltd.

Price

$2.57

return (12m)

76.90%

p/e

7.22

p/bv

2.86

DIVIDEND YIELD

0.00%

CGEN price

Compugen

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CGEN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

8.92%

3 months

-8.39%

1 year

76.90%

2 years

25.74%

5 years

-61.54%

10 years

-62.39%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals CGEN

Valuation

P/E

7.22

Sector -0.74

Industry 5.42

P/BV

2.86

Sector 1.97

Industry 3.88

P/Revenue (PSR)

3.43

Sector 1.74

Industry 3.79

EV/EBITDA

-14.57

Sector -8.33

Industry 25.54

EV/EBIT

-14.57

Sector -14.02

Industry -11.16

P/EBITDA

8.39

Sector -44.73

Industry 9.99

P/EBIT

8.39

Sector -45.73

Industry -8.23

P/Total Assets

1.84

Sector 0.91

Industry 1.49

P/Net Current Assets

3.19

Sector -25.37

Industry -4.37

P/Working Capital

2.38

Sector -5.79

Industry 5.81

EPS

0.37

Sector -0.83

Industry -0.21

BVPS

0.93

Sector 3.91

Industry 6.45

Efficiency

Gross Margin

86.89%

Sector 45.33%

Industry 54.34%

EBITDA Margin

-340.00%

Sector -312.56%

Industry -12.07%

EBIT Margin

-340.00%

Sector -198.10%

Industry -24.61%

Operating Margin

40.93%

Sector -23.11%

Industry -3.00%

Net Profit Margins

47.54%

Sector -28.02%

Industry -7.67%

Asset Turnover

0.02

Sector 0.13

Industry 0.12

Profitability

ROE

39.65%

Sector -29.59%

Industry -24.14%

ROA

25.42%

Sector -28.62%

Industry -6.01%

ROIC

-146.56%

Sector -521.05%

Industry -16.46%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

5.72

Sector 1.85

Industry 2.52

Net Debt / EBITDA

14.17

Sector -1.07

Industry 10.38

Net Debt / EBIT

14.17

Sector -1.09

Industry 6.00

Net Debt / Equity

-1.41

Sector -0.34

Industry 0.01

Gross Debt / Equity

0.00

Sector 0.14

Industry 0.55

Equity/Assets

0.64

Sector 0.43

Industry 0.46

Liabilities/Assets

0.36

Sector 0.48

Industry 0.53

Growth

5Y Revenue CAGR

65.28%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF Compugen ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$2.57

Fair Value

$2.78

Upside Return potential.

8.48%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals CGEN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CGEN Compugen Ltd.	$2.57	76.90%	0.00%	7.22	2.86	39.65%	47.54%
TMO Thermo Fisher Scientific Inc.	$622.96	25.14%	0.29%	33.21	4.38	13.19%	15.04%
DHR Danaher Corporation	$216.41	2.93%	0.66%	38.57	2.94	7.61%	15.95%
WAT Waters Corporation	$409.95	35.66%	0.00%	241.26	2.64	1.09%	3.58%
IQV IQVIA Holdings Inc.	$260.14	36.09%	0.00%	124.50	27.17	21.82%	8.10%
SHC Sotera Health Company	$19.11	16.31%	0.00%	33.72	8.28	24.56%	13.44%
SYNH Syneos Health Inc.	$0.00	-	0.00%	62.97	1.28	2.04%	1.31%
LLY Eli Lilly and Compay	$1,242.93	76.14%	0.51%	42.15	33.23	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$376.05	-21.02%	0.00%	42.99	7.38	17.15%	28.45%
SNY Sanofi	$45.64	-7.62%	3.84%	7.49	1.38	18.43%	13.81%
NVS Novartis AG	$158.24	27.04%	1.95%	23.74	7.22	30.41%	22.50%
ABT Abbott Laboratories	$116.78	-9.91%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$93.36	4.78%	3.08%	24.65	2.36	9.59%	13.20%
GSK GlaxoSmithKline PLC	$51.61	34.32%	3.38%	16.11	4.55	28.24%	14.54%
CVS CVS Health Corporation	$93.09	34.69%	2.86%	24.36	1.49	6.12%	1.18%
BSX Boston Scientific Corp.	$49.36	-53.51%	0.00%	18.39	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$92.53	-22.80%	0.00%	21.76	6.37	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$555.84	-13.90%	0.00%	38.42	27.15	70.67%	25.03%
RMD ResMed Inc.	$232.29	-19.91%	1.03%	22.16	5.13	23.13%	26.94%
HCA HCA Healthcare Inc.	$430.50	7.00%	0.70%	13.87	-29.56	-213.15%	8.77%
COHR Coherent Inc.	$276.10	207.12%	0.00%	69.45	4.98	7.16%	11.31%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CGEN Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Compugen

Compugen Ltd.

Average Investor10 user rating

4.0 (1 people)

United States

33 years

Founded: 1993

2000

Time since IPO - 26 years

68

Employees

Compugen Ltd. (United States) is listed on the Nasdaq and has a market capitalization of $254.13 million, with shareholders equity totaling $88.73 million.

The company employs approximately 68 people and operates in the Health sector, within the Life Science Tools and Services industry.

Over the past 12 months, Compugen Ltd. reported $74.00 million in revenue, generating net income of $35.18 million.

Key financial metrics include a P/E ratio of 7.22, a price-to-book (P/B) ratio of 2.86, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CGEN.

Market cap

$254.13 million

Net worth

$88.73 million

$88,730,000.00

Assets

$138.37 million

$138,370,000.00

Total Shares Outstanding

95.00 million

95,000,000

Average Daily Trading Volume

$283.37 Thousand

$283,369.96

Sector

Health

Industry

Life Science Tools and Services

CGEN

CGEN revenue and profits

Financial Results CGEN

DRAG THE FRAME TO SEE MORE DATA

CGEN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.09 34,69% (12M)

P/E

24.36

2.86%

ROE

6.12%

P/BV

1.49

CI - Cigna

$278.76 --5,87% (12M)

P/E

10.67

2.22%

ROE

16.04%

P/BV

1.71

CNC - Centene

$65.86 123,94% (12M)

P/E

-6.26

0.00%

ROE

-22.51%

P/BV

1.41

HUM - Humana

$382.82 29,66% (12M)

P/E

35.89

0.93%

ROE

6.63%

P/BV

2.38

SNY - Sanofi

$45.64 --7,62% (12M)

P/E

7.49

3.84%

ROE

18.43%

P/BV

1.38

LLY - Eli Lilly

$1,242.93 80,28% (12M)

P/E

42.15

0.51%

ROE

78.84%

P/BV

33.23

HCA - HCA Healthcare

$430.50 7,00% (12M)

P/E

13.87

0.70%

ROE

-213.15%

P/BV

-29.56

NVS - Novartis

$158.24 27,04% (12M)

P/E

23.74

1.95%

ROE

30.41%

P/BV

7.22